Core Viewpoint - The company, Puluo Pharmaceutical Co., Ltd., has received a notice from its controlling shareholder, Hengdian Group Holdings Co., Ltd., regarding the increase in shareholding by its concerted action party, Dongyang Hengdian Yushan Sports Leisure Co., Ltd. This increase has brought the total shareholding of the controlling shareholder and its concerted action parties to 52.03% [2][4]. Group 1: Shareholding Changes - On January 13, 2026, Yushan Sports increased its shareholding by 1,653,500 shares, accounting for 0.14% of the company's total share capital, with a total investment of RMB 28,695,970 [2][4]. - Prior to this increase, Yushan Sports held 9,241,603 shares, representing 0.80% of the total share capital, while the total shareholding of the controlling shareholder and its concerted action parties was 51.89% [3][4]. Group 2: Future Shareholding Plans - Yushan Sports plans to increase its shareholding by an amount not less than RMB 60 million and not exceeding RMB 120 million within six months from January 13, 2026 [2][4]. - The increase will be executed through centralized bidding on the Shenzhen Stock Exchange, without a set price range, considering the intrinsic value of the stock and market trends [4][5]. Group 3: Funding and Commitments - The funds for the share purchase will come from Yushan Sports' own or raised funds [6]. - Yushan Sports has committed not to reduce its shareholding during the implementation period of the increase plan and will adhere to relevant regulations [6][10]. Group 4: Regulatory Compliance - The shareholding increase will not affect the company's compliance with listing conditions or change its control [8]. - Yushan Sports will maintain the increase amount unchanged in case of any corporate actions such as stock splits or dividends during the implementation period [9].

佰维存储等公司预计2025年净利润翻番；容百科技：与宁德时代签署采购合作协议预计销售金额超1200 亿元；锋龙股份：公司股价短期内涨幅较大 14日起停牌核查；普洛药业：控股股东之一致行动人拟以 0.6亿至1.2亿元增持公司股份…… 聚焦一：佰维存储等公司预计2025年净利润翻番 佰维存储：披露业绩预告。经财务部门初步测算，公司预计2025年实现营业收入1,000,000.00万元至 1,200,000.00万元，与上年同期（法定披露数据）相比，将增加330,481.49万元至530,481.49万元，同比 增长49.36%至79.23%。预计2025年度实现归属于母公司所有者的净利润85,000.00万元至100,000.00万 元，与上年同期（法定披露数据）相比，将增加68,876.66万元至83,876.66万元，同比增加427.19%至 520.22%。 公司表示：从2025年第二季度开始，随着存储价格企稳回升，公司重点项目逐步交付，公司销售收入和 毛利率逐步回升，经营业绩逐步改善。2025年度公司在AI新兴端侧领域保持高速增长趋势，并持续强 化先进封装能力建设，晶圆级先进封测制造项目整体进展顺利，目前 ...

Group 1 - Hongsheng Co., Ltd. has not generated revenue in the data center liquid cooling sector [1] - Oriental Pearl does not directly engage in AI business, and AI applications do not directly generate revenue [1] - Tongda Hai's AI-driven revenue accounts for a low proportion of the company's overall operating income [1] Group 2 - Beibu Gulf Port plans to invest 11.403 billion yuan in the construction of a 300,000-ton terminal project in Fangchenggang [1] - Beibu Gulf Port also plans to invest in the construction of the Beibu Gulf Port Beihai Port area Tiezhong Port District No. 4 and No. 5 berth project [1] - LeKai Film's subsidiary plans to invest 97.6675 million yuan in a TAC functional film coating production line project [1] Group 3 - Aopt plans to undertake a 120 million yuan 2D vision solution project for Goer [1] - Wantong Expressway has won a project worth 7.237 billion yuan [1] - Pingzhi Information is expected to win a project worth 37.5884 million yuan [1] Group 4 - Aidi Pharmaceutical intends to acquire a 22.2324% stake in Nanda Pharmaceutical for 130 million yuan [1] - Kaifa Electric plans to repurchase shares worth 30 million to 60 million yuan [1] - Haojiang Intelligent plans to repurchase shares worth 1.5 million to 3 million yuan [1] Group 5 - Huazhi Jie plans to spend 30 million to 50 million yuan on share repurchase [2] - New Work Group intends to reduce its stake in China New Group by no more than 3% [2] - Zhejiang Yongqiang's shareholder plans to reduce its stake by no more than 1.13% [2] Group 6 - Shandong Pharmaceutical Glass plans to raise no more than 3.235 billion yuan through a private placement [2] - Fulin Precision plans to raise 3.175 billion yuan through a private placement to Ningde Times [2] - Yuanwang Valley plans to raise no more than 690 million yuan through a private placement [2]

Group 1: Share Buybacks and Increases - Prolo Pharmaceutical's controlling shareholder plans to increase its stake by 60 million to 120 million yuan [3] - BAIC Blue Valley and some directors and executives plan to increase their holdings by 14.5 million to 16.4 million yuan [3] - Zhongju High-tech has obtained a commitment letter for a stock repurchase loan of 540 million yuan from a financial institution [3] - Haojiang Intelligent plans to use its own funds to repurchase shares for equity incentives or employee stock ownership plans [3] - Huazhi Jie intends to repurchase shares worth 30 million to 50 million yuan [3] - Nanshan Aluminum plans to repurchase shares worth 300 million to 600 million yuan for cancellation [3] Group 2: Share Reductions - New Work Group, a shareholder of Zhongxin Group, plans to reduce its stake by no more than 3% [3] - Hongqi Technology's shareholders plan to reduce their holdings by no more than 4.68% [3] - Zhejiang Yongqiang's shareholder, Xie Jianqiang, plans to reduce his stake by no more than 1.13% [3] - Xiangyu Medical's shareholder, Anyang Qixu, plans to reduce his stake by no more than 3% [3] - Shuyuan Pingmin's shareholder, Ali Health, plans to reduce his stake by no more than 2% [3] - Hongqiang Co., Ltd.'s actual controller plans to reduce no more than 2.1161 million shares, not exceeding 1% of the total share capital [3] - China Merchants Shipping's directors and executives plan to collectively reduce their holdings by no more than 648,600 shares [3] - Zhang Yijie, a shareholder of Jixin Technology, plans to reduce his stake by no more than 1% [3] - Dingjie Smart's major shareholder, Industrial Fulian, reduced its stake by 1.14% from January 9 to January 12 [3] - Zhongli Co., Ltd.'s shareholders plan to reduce their holdings by no more than 0.75% [3]

Group 1: Company Announcements - Hongsheng Co., Ltd. has not generated revenue in the data center liquid cooling sector [1][2] - Oriental Pearl does not directly engage in AI business, and AI applications do not directly generate revenue [1][2] - Tongda Hai's AI-driven revenue accounts for a low proportion of the company's overall operating income [2] Group 2: Project Investments - Beibu Gulf Port plans to invest 11.403 billion yuan in the construction of a 300,000-ton terminal project in Fangcheng Port [1][2] - LeKai Film's subsidiary plans to invest 97.6675 million yuan in a TAC functional film coating production line project [2] Group 3: Contract Awards - Aopt has won a bid for a 120 million yuan 2D vision solution project for GoerTek in 2026 [1][2] - Anhui Expressway has won a project worth 7.237 billion yuan [2] Group 4: Equity Transfers - Aidi Pharmaceutical intends to acquire a 22.2324% stake in Nanda Pharmaceutical for 130 million yuan [1][2] Group 5: Share Buybacks - Kaifa Electric plans to repurchase shares worth between 30 million and 60 million yuan [1][2] - Haojiang Intelligent plans to repurchase shares worth between 1.5 million and 3 million yuan [3] - Huazhi Jie plans to invest 30 million to 50 million yuan in share repurchases [3] Group 6: Shareholding Changes - New Work Group, a shareholder of China New Group, plans to reduce its stake by no more than 3% [3] - Zhejiang Yongqiang's shareholder plans to reduce his stake by no more than 1.13% [3] - Xiangyu Medical's shareholder plans to reduce his stake by no more than 3% [3]

Group 1 - Hangxiao Steel Structure announced that it does not have a "commercial aerospace" business, with its main operations focused on steel structure contracting and related services, and a recent project contributing less than 1% to its 2024 audited revenue [1] - Tianlong Group stated that it has not generated additional revenue from AI tools, which are currently used internally for advertising content creation, and that the overall business operations remain unaffected [1] - Wanxing Technology confirmed that there are no undisclosed significant matters affecting its operations, and its business environment remains stable [2] Group 2 - Yaxing Chemical announced the termination of a share issuance and cash purchase of assets due to market changes and disagreements on asset valuation [2] - Zhejiang Shuculture clarified that its subsidiaries do not engage in GEO business, which has been misreported by media [2] - Luxshare Precision terminated the acquisition of assets from Wintime Technology due to delivery restrictions, with a request for the return of 1.53 billion RMB [3] Group 3 - Jinyu Group reported that its subsidiaries' revenues from specific projects are minimal compared to its overall revenue, with a small contribution from recent contracts [4] - Tongyu Communication highlighted that its stock price has significantly outpaced its fundamentals, indicating potential risks of a price correction [4] - Dongfang Mingzhu noted that the listing process for its investment in Chaoguhuan has uncertainties but currently does not impact its performance [5] Group 4 - Luyin Investment warned of risks associated with its stock price surge, which has increased by 86.92% over the last ten trading days [5] - Puyuan Information stated that its AI software platform is in the early commercialization stage, with limited revenue impact expected [6] - Zhejiang Wenhu Intermediary reported that its GEO business has not yet generated revenue, reflecting uncertainties in market acceptance [6] Group 5 - Xinhua News confirmed that its GEO business lacks a mature profit model and has not generated income [7] - People's Daily stated that it does not engage in GEO business and has not been affected by market rumors [7] - China First Heavy Industries reported minimal involvement in controllable nuclear fusion projects, with no significant revenue generated [8] Group 6 - Xibu Mining announced an increase in copper resources at the Yulong Copper Mine, adding 131.42 million tons of copper metal resources [8] - Jiurui New Materials commenced trial production of a new photoinitiator project, expected to cater to mainstream markets [9] - Tongda Sea indicated that AI-related revenue is low and does not significantly impact overall business performance [10] Group 7 - Zhenai Meijia's stock price has deviated significantly from market indices, prompting caution for investors [11] - Guizhou Moutai approved a new marketing strategy to enhance its sales channels and adapt to consumer demands [12] - Shunhao Co. plans to increase its stake in a subsidiary, reflecting confidence in future business prospects [14] Group 8 - A number of companies, including TCL Technology and Dazhu CNC, forecast significant profit increases for 2025, driven by operational improvements and market demand [19][22] - Long Cable Technology expects a profit increase due to changes in its employee stock plan and market conditions [22] - Jiangsu Electric Power reported a profit increase attributed to higher sales and reduced financial costs [29]

Core Viewpoint - Prolo Pharmaceutical (000739.SZ) announced that its controlling shareholder, Hengdian Group, through its action-in-concert party, Dongyang Hengdian Yushan Sports Leisure Co., Ltd. (referred to as "Yushan Sports"), has increased its shareholding in the company, indicating a positive outlook on the company's future performance [1] Group 1 - Yushan Sports acquired 1,653,500 shares of Prolo Pharmaceutical on January 13, 2026, representing 0.14% of the company's total share capital, with a total investment of approximately RMB 28,695,970 [1] - Following this transaction, the combined shareholding of the controlling shareholder and its action-in-concert parties reached 52.03%, triggering a change in equity that touches the 1% integer multiple [1] Group 2 - Yushan Sports plans to further increase its shareholding within six months starting from January 13, 2026, with a minimum investment of RMB 60 million and a maximum of RMB 120 million, including the amount already invested [1]

证券代码：000739 证券简称：普洛药业 公告编号：2026-04 普洛药业股份有限公司 关于控股股东一致行动人增持公司股份暨权益变动触及 1% 整数倍及后续增持计划的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1.普洛药业股份有限公司（以下简称"公司"）于 2026 年 1 月 13 日收到控 股股东横店集团控股有限公司之一致行动人东阳市横店禹山运动休闲有限公司 （以下简称"禹山运动"）出具的《东阳市禹山运动休闲有限公司关于增持普洛 药业股份暨权益变动触及 1%整数倍及后续增持计划的告知函》，2026 年 1 月 13 日，禹山运动通过深圳证券交易所交易系统以集中竞价交易方式增持公司股份 1,653,500 股，占公司总股本的 0.14%，增持金额共计人民币 28,695,970 元，公 司控股股东及其一致行动人合计持有公司股份比例达到 52.03%，权益变动触及 1%整数倍。 2.禹山运动计划自 2026 年 1 月 13 日起 6 个月内，以自有资金或自筹资金通 过集中竞价交易方式增持公司股份，拟增持公司股份金额不低于人民币 0. ...

Group 1 - The core point of the announcement is that Yushan Sports, a concerted action party of the controlling shareholder, has increased its stake in Prologis Pharmaceuticals by acquiring 1.6535 million shares, which represents 0.14% of the total share capital, for a total amount of 28.69597 million yuan [1] - Following this acquisition, the combined shareholding of the controlling shareholder and its concerted action parties has reached 52.03%, triggering a change in equity that touches upon the 1% integer multiple [1] - Yushan Sports plans to further increase its stake in the company within six months starting from January 13, with an investment amount not less than 60 million yuan and not exceeding 120 million yuan (including this acquisition) [1] Group 2 - Yushan Sports has committed to not reducing its holdings during the increase period and the statutory period [1] - The planned increase may be subject to market changes, which could result in partial or complete non-implementation of the plan [1]

1月13日，A股三大股指早盘冲高回落，午后震荡下跌，截止收盘，上证综指下跌26.53点，跌幅0.64% 报4138.76点；深证成指下跌197.51点，跌幅1.37%报14169.4点；沪深300指数下跌28.88点，跌幅0.6%报 4761.03点；创业板指下跌66.45点，跌幅1.96%报3321.89点；科创50指数下跌42.27点，跌幅2.8%报 1469.57点；盘中创业板指一度跌超2%，沪指跌近1%；全天成交额较昨日再度放量，两市成交额录得 3.65万亿再创历史新高，两市超3500只个股下跌。 盘面上，AI应用概念逆势上涨，十余只成分股涨停，引力传媒、利欧股份、省广集团涨停。AI医疗概 念反复活跃，美年健康3连板，泓博医药、新赣江等多股涨停。电网设备概念午后走强，特变电工、三 变科技涨停；零售概念表现活跃，三江购物2连板；贵金属板块走高，晓程科技涨超8%；减肥药板块拉 升，普洛医药逼近涨停；创新药、锂矿概念及游戏等板块涨幅居前。下跌方面，多家公司公告提示风 险，商业航天、卫星互联网板块大退潮，航天电子、中国卫通、航天科技等近百股跌超8%；大飞机、 军工板块走低，中天火箭、雷科防务等多股跌停；可控核 ...